Navigation Links
VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
Date:6/11/2009

-- the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291; -- if the results of the ACS and CEA studies, upon further review and analysis, are revised or negated by authorities or by later stage clinical trials; -- our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291; -- our ability to successfully commercialize VIA-2291; -- our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development; -- our ability to obtain and protect our intellectual property related to our product candidates; -- our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche; -- our ability to obtain strategic opportunities to partner and collaborate with large biotechnology or pharmaceutical companies to further develop VIA-2291; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item 1A "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, as supplemented by the risks described under Item 1A "Risk Factors" in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, on file with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and VIA undertakes no obligation to update publicly any of these statements in light of n
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
2. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
3. ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
4. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
5. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
6. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
7. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
8. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
9. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
10. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
(Date:7/23/2014)... , July 23, 2014 Creekridge ... have added 14 new vendors so far in ... Creekridge,s newest vendors are from both the ... domestic organizations to large, well-known multi-national companies. Each ... diversified suite of financing products including: standard leasing ...
(Date:7/23/2014)...  When it comes to welcoming our new robot overlords, ... out the red carpet. Healthcare is one of ... robots into our human sphere. With healthcare concerns top of ... to apply new technologies to help with old problems. That,s ... is expected to increase from $1.7 billion now to $3.7 ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Creekridge Capital Signs Several New Vendor Partners 2
... May 4 /PRNewswire-Asia-FirstCall/ -- Pharmaceutical,company Pharmaxis (ASX: PXS; Nasdaq: ... of its recently completed international Phase III trial of,Bronchitol(TM) ... one of,the largest clinical trials conducted in cystic fibrosis. ... the trial was to assess whether Bronchitol,improves lung function ...
... Calif., May 1 Isis Pharmaceuticals, Inc. (Nasdaq: ... presented data on numerous advanced programs from Isis, cardiovascular ... Thrombosis and Vascular Biology,s (ATVB) Annual Conference. The ... recently completed clinical study of mipomersen in which treatment ...
Cached Medicine Technology:Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 2Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 3Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 4Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 5Isis and Collaborators Present New Research at the ATVB Annual Conference 2Isis and Collaborators Present New Research at the ATVB Annual Conference 3Isis and Collaborators Present New Research at the ATVB Annual Conference 4Isis and Collaborators Present New Research at the ATVB Annual Conference 5
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
(Date:7/24/2014)... Florida (PRWEB) July 24, 2014 After waiting ... and multiple injections later, Mrs. Ackerman decided it was time ... letter . She knew a surgical intervention was needed ... contacted the Orthopedic and Laser Spine Surgery Center for help. ... were sincere and professional. Even living in Montana, the connection ...
(Date:7/24/2014)... 24, 2014 Wisdom Natural Brands®, the ... SweetLeaf Stevia® Sweetener and Wisdom of the Ancients® herbal ... implementing innovative, high growth strategies. , Carol May, ... the executive leadership team today. “We are honored to ... brands into the future. The executives bring an impressive ...
(Date:7/24/2014)... 24, 2014 Professional Healthcare at Home, an ... Karen Schulkin, a nurse with the company’s Pleasant Hill, CA, ... Finalist for the 2014 Home Care & Hospice Nurse of ... Care & Hospice (NAHC). , Annually, NAHC promotes a ... public to help choose a top home care and hospice ...
(Date:7/24/2014)... July 24, 2014 According to ... 332,000 total hip replacements are performed in the ... Rosa Orthopedics (SRO) is a board certified orthopedic ... and pelvic & acetabular reconstruction. He specializes in ... minimally invasive technique that requires special training and ...
Breaking Medicine News(10 mins):Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 2Health News:Wisdom Natural Brands Announces Key Executive Management Team 3Health News:Wisdom Natural Brands Announces Key Executive Management Team 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 5Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 2Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 3Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 4
... different behavior to more time to cope, , MONDAY, ... how much time people have to react has a ... selflessly, if a new critique of the infamous Titanic ... The comparative look at who survived two of the ...
... ... Mattress Firm is pleased to announce they have joined forces with ... based in Houston, TX, is the nation,s leading specialty retailer of conventional ... full service, boutique franchise consulting firm with offices across the country. ...
... , ... ... ... ...
... ... ... ... ...
... ... ... ... ...
... team of researchers at UMass Lowell has found a new ... can spread within the human brain. The research, led ... hope that the disease may someday be cured. It provides ... human protein that becomes toxic in Alzheimer,s patients, can appear ...
Cached Medicine News:Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 2Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 3Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 4Health News:Mattress Firm Partners with Upside Group Franchise Consulting 2Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 4Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 5Health News:Chilean Quake Survivors Need Help: PADF 2Health News:Chilean Quake Survivors Need Help: PADF 3Health News:Chilean Quake Survivors Need Help: PADF 4Health News:Chilean Quake Survivors Need Help: PADF 5Health News:Chilean Quake Survivors Need Help: PADF 6Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 2Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 3Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 4Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 5Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: